{"id":"local-standard-of-care","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL261657","moleculeType":"Small molecule","molecularWeight":"405.37"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is not a single drug entity but rather a comparator arm representing the institutional standard treatment regimen. It typically includes conventional chemotherapy, targeted therapy, immunotherapy, or combinations thereof based on current clinical guidelines and institutional practice for the specific cancer type being studied.","oneSentence":"Local Standard of Care refers to the established treatment protocols and therapeutic approaches used at Istituto Oncologico Veneto IRCCS for cancer management, which vary by tumor type and patient characteristics.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:52:44.836Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Various cancers as per institutional standard treatment protocols"}]},"trialDetails":[{"nctId":"NCT00980538","phase":"PHASE3","title":"TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Sciences Ireland UC","startDate":"2009-12-09","conditions":"HIV Infections, HIV-1","enrollment":180},{"nctId":"NCT03784755","phase":"NA","title":"Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2019-11-15","conditions":"Prostate Cancer Metastatic","enrollment":409},{"nctId":"NCT06824467","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-04-09","conditions":"Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer","enrollment":770},{"nctId":"NCT06295809","phase":"PHASE2, PHASE3","title":"A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-04-18","conditions":"Carcinoma, Squamous Cell, Skin Neoplasms","enrollment":46},{"nctId":"NCT06527872","phase":"","title":"Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN","status":"RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2024-10-04","conditions":"Lupus Nephritis","enrollment":300},{"nctId":"NCT06275919","phase":"PHASE2","title":"Regorafenib for Recurrent Meningioma (MIRAGE Trial)","status":"RECRUITING","sponsor":"Istituto Oncologico Veneto IRCCS","startDate":"2024-09-23","conditions":"Meningioma, Malignant","enrollment":104},{"nctId":"NCT03387553","phase":"EARLY_PHASE1","title":"HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2018-06-06","conditions":"Breast Cancer, Breast Cancer Female, Breast Cancer, Male","enrollment":31},{"nctId":"NCT05165810","phase":"NA","title":"Evaluation of Multiple Interventions to Improve HIV Treatment Outcomes Among People Who Inject Drugs in India","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-03-09","conditions":"HIV Infections","enrollment":800},{"nctId":"NCT06974916","phase":"NA","title":"EMBRACE Tremor BiFUS","status":"RECRUITING","sponsor":"InSightec","startDate":"2025-04-22","conditions":"Essential Tremor","enrollment":100},{"nctId":"NCT05461092","phase":"EARLY_PHASE1","title":"Regional Nerve Blocks to Improve Analgesia and Recovery in Older Adults Undergoing Spinal Fusion","status":"RECRUITING","sponsor":"University of Iowa","startDate":"2024-01-01","conditions":"Delirium, Pain, Back, Spinal Fusion","enrollment":50},{"nctId":"NCT06346197","phase":"PHASE3","title":"Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas","status":"RECRUITING","sponsor":"Centre Leon Berard","startDate":"2025-12-08","conditions":"Gastric Cancer, MSI-H, Metastatic Cancer","enrollment":132},{"nctId":"NCT07492498","phase":"NA","title":"Telemedicine-Based Integrated Care for Heart Failure Prevention in Older Patients With Atrial Fibrillation (MIRACLE-AF III)","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Taizhou People's Hospital","startDate":"2026-04-01","conditions":"Atrial Fibrillation, Heart Failure","enrollment":1268},{"nctId":"NCT07492121","phase":"PHASE2","title":"Screening for Brain Metastases","status":"NOT_YET_RECRUITING","sponsor":"University of Zurich","startDate":"2026-09","conditions":"Lung Cancer Stage IV, Melanoma Stage IV, Breast Cancer Metastatic","enrollment":180},{"nctId":"NCT05972551","phase":"PHASE3","title":"Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta","status":"RECRUITING","sponsor":"Amgen","startDate":"2024-04-22","conditions":"Osteogenesis Imperfecta","enrollment":106},{"nctId":"NCT05993442","phase":"NA","title":"Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk Infants in NICU.","status":"RECRUITING","sponsor":"PENTA Foundation","startDate":"2024-05-28","conditions":"Infection, Bacterial, Infection Prevention","enrollment":3080},{"nctId":"NCT07491419","phase":"NA","title":"The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST)","status":"RECRUITING","sponsor":"Istituto Clinico Humanitas","startDate":"2025-11-19","conditions":"Bloodstream Infection, Gram-Negative Infections, Gram-Positive Infections","enrollment":400},{"nctId":"NCT06476639","phase":"PHASE3","title":"A Phase III Randomised Clinical Trial of Ultrasound Groin Monitoring Versus Groin Lymph Node Dissection to De-Escalate the Extent of Surgery in Vulvar Cancer","status":"NOT_YET_RECRUITING","sponsor":"Queensland Centre for Gynaecological Cancer","startDate":"2026-06-01","conditions":"Vulvar Cancer Stage I, Vulvar Cancer Stage II, Lymph Node Metastasis","enrollment":640},{"nctId":"NCT06593080","phase":"NA","title":"The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis","status":"RECRUITING","sponsor":"Chishala Chabala","startDate":"2024-06-01","conditions":"Tuberculosis, Child Health, HIV","enrollment":30240},{"nctId":"NCT06253715","phase":"PHASE3","title":"Shortened Regimen for Drug-susceptible TB in Children","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-01-15","conditions":"Tuberculosis, Tuberculosis, Pulmonary, Tuberculosis, Lymph Node","enrollment":860},{"nctId":"NCT07489664","phase":"NA","title":"Indigenous Nutritional Supplements for Pregnancy to Improve Resilience in Environmental Heat","status":"NOT_YET_RECRUITING","sponsor":"Aga Khan University","startDate":"2026-03","conditions":"Heat Stress, Pregnancy, Women of Reproductive Age","enrollment":292},{"nctId":"NCT05373940","phase":"NA","title":"Cardioverter DefIbriIlator PlacEMent for priMary Prevention of Sudden cArdiac Death in Patients Older Than 70 Years","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-06-29","conditions":"Heart Failure, Primary Prevention of Sudden Cardiac Death, Implantable Cardioverter Defibrillator","enrollment":730},{"nctId":"NCT05142605","phase":"NA","title":"Evaluation of Grief Therapy Approaches for Bereaved Parents","status":"RECRUITING","sponsor":"University of Miami","startDate":"2022-03-31","conditions":"Grief, Bereavement, Cancer","enrollment":415},{"nctId":"NCT07479199","phase":"","title":"Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors","status":"NOT_YET_RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2026-03-20","conditions":"Thoracic Neoplasms, Lumbar Neoplasm","enrollment":70},{"nctId":"NCT05758077","phase":"NA","title":"Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury","status":"RECRUITING","sponsor":"SeaStar Medical","startDate":"2023-04-17","conditions":"Acute Kidney Injury","enrollment":339},{"nctId":"NCT06282575","phase":"PHASE3","title":"Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer","status":"RECRUITING","sponsor":"Jazz Pharmaceuticals","startDate":"2024-07-19","conditions":"Biliary Tract Cancer","enrollment":286},{"nctId":"NCT07357493","phase":"NA","title":"metaCARpal Bone Osteosynthesis Trail","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2026-03-23","conditions":"Metacarpal Shaft Fractures","enrollment":552},{"nctId":"NCT07489274","phase":"PHASE4","title":"Adjunctive Hyperbaric Oxygen Treatment for Patients With Necrotizing Soft-Tissue Infection (HOT-NSTI Trial). Investigator-initiated, International, Multicentre, Superiority, Randomized, Open-label, Clinical Trial.","status":"NOT_YET_RECRUITING","sponsor":"Ole Hyldegaard","startDate":"2027-04-01","conditions":"Necrotizing Soft Tissue Infection","enrollment":1480},{"nctId":"NCT06955169","phase":"PHASE2","title":"Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment","status":"RECRUITING","sponsor":"RTOG Foundation, Inc.","startDate":"2025-12-24","conditions":"Intracranial Meningioma","enrollment":153},{"nctId":"NCT04083378","phase":"PHASE2","title":"Software-Aided Imaging (Morfeus) for Confirming Tumor Coverage With Ablation in Patients With Liver Tumors, the COVER-ALL Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-01-10","conditions":"Malignant Liver Neoplasm","enrollment":107},{"nctId":"NCT03737149","phase":"NA","title":"A Prospective Multicenter Longitudinal Cohort Study of the Mymobility Platform","status":"COMPLETED","sponsor":"Zimmer Biomet","startDate":"2018-10-22","conditions":"Osteoarthritis, Knee, Osteoarthritis, Hip","enrollment":6559},{"nctId":"NCT07462663","phase":"","title":"SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer","status":"NOT_YET_RECRUITING","sponsor":"Hospital Universitari de Bellvitge","startDate":"2026-05","conditions":"Endometrial Cancer, Endometrial Cancer Stage I, Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I","enrollment":82},{"nctId":"NCT06803771","phase":"NA","title":"Surveillance of Pancreatic Health After Diabetes Diagnosis","status":"RECRUITING","sponsor":"University Hospital Southampton NHS Foundation Trust","startDate":"2025-05-21","conditions":"Diabetes Mellitus, Pancreatic Cancer, Adult","enrollment":15000},{"nctId":"NCT05161078","phase":"","title":"Improving Continuous Renal Replacement Therapy Outcomes in Neonates and Infants Through Interdisciplinary Collaboration","status":"ENROLLING_BY_INVITATION","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2021-12-16","conditions":"Acute Kidney Injury, Chronic Kidney Diseases, Renal Dialysis","enrollment":1000},{"nctId":"NCT07001748","phase":"PHASE2, PHASE3","title":"Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity","status":"RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2025-08-19","conditions":"Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis","enrollment":148},{"nctId":"NCT03663335","phase":"PHASE2","title":"Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2018-11-28","conditions":"Kidney Transplantation","enrollment":418},{"nctId":"NCT07488754","phase":"NA","title":"Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)","status":"RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2025-10-01","conditions":"Glioblastoma, High-Grade Glioma (WHO III-IV), Glioblastoma (GBM)","enrollment":35},{"nctId":"NCT04848883","phase":"NA","title":"Infectious Diseases Experts as Part of the Antibiotic Stewardship Team in Primary Care","status":"COMPLETED","sponsor":"Institut d'Investigació Biomèdica de Bellvitge","startDate":"2021-06-01","conditions":"Infectious Disease","enrollment":1389},{"nctId":"NCT06656988","phase":"PHASE3","title":"A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Major Adverse Kidney Events (MAKE)","status":"RECRUITING","sponsor":"University of Leipzig","startDate":"2025-04-14","conditions":"Peripheral Vascular Diseases, Kidney Diseases","enrollment":1960},{"nctId":"NCT05658003","phase":"PHASE2","title":"A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-05-05","conditions":"Metastatic Castration-Resistant Prostate Cancer (mCRPC)","enrollment":63},{"nctId":"NCT03037164","phase":"PHASE3","title":"INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cerus Corporation","startDate":"2017-05-11","conditions":"Anemia","enrollment":692},{"nctId":"NCT07484932","phase":"NA","title":"TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2026-05-01","conditions":"Cancer (Solid Tumors), Geriatric Oncology","enrollment":400},{"nctId":"NCT07169851","phase":"PHASE2","title":"A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-11-28","conditions":"Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions","enrollment":204},{"nctId":"NCT05806645","phase":"NA","title":"UPTAKE: Using Personalized Risk and Digital Tools to Guide Transitions Following Acute Kidney Events","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2025-02-12","conditions":"Acute Kidney Injury","enrollment":6046},{"nctId":"NCT07436650","phase":"NA","title":"Efficacy of High-Level Laser Therapy in Managing Oral Mucositis Among Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-06-15","conditions":"Oral Mucositis","enrollment":14},{"nctId":"NCT06589596","phase":"PHASE1","title":"An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors","status":"RECRUITING","sponsor":"BeOne Medicines","startDate":"2024-10-11","conditions":"Advanced Solid Tumor","enrollment":244},{"nctId":"NCT07483229","phase":"NA","title":"A Clinical Study on Warm Needling Moxibustion at Tianshu and Guanyuan Acupoints","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Henan University of Traditional Chinese Medicine","startDate":"2022-08-01","conditions":"Constipation - Functional","enrollment":60},{"nctId":"NCT07483060","phase":"PHASE4","title":"Next Generation STAR-TREC (NG-ST) - Organ Preservation in Early Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Vastra Gotaland Region","startDate":"2026-03-12","conditions":"Rectal Cancer","enrollment":90},{"nctId":"NCT07322822","phase":"NA","title":"Active Coping Program for Chronic Musculoskeletal Pain: A Controlled Clinical Study","status":"NOT_YET_RECRUITING","sponsor":"Universidad de Extremadura","startDate":"2026-03-01","conditions":"Chronic Musculoskeletal Pain, Chronic Pain","enrollment":60},{"nctId":"NCT05373758","phase":"NA","title":"A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan Africa","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-02-07","conditions":"HIV Infections, AIDS, Virologic Failure","enrollment":648},{"nctId":"NCT04899908","phase":"PHASE2","title":"Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2021-09-15","conditions":"Brain Cancer, Brain Metastases, Melanoma","enrollment":134},{"nctId":"NCT06998524","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-06-27","conditions":"Von Willebrand Disease, Type 3","enrollment":75},{"nctId":"NCT03596645","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2018-10-29","conditions":"Colitis, Ulcerative","enrollment":84},{"nctId":"NCT07481305","phase":"NA","title":"Lifestyle Change Implementation Research Network at PRC at UMass Chan","status":"NOT_YET_RECRUITING","sponsor":"University of Massachusetts, Worcester","startDate":"2026-04-15","conditions":"GLP - 1","enrollment":220},{"nctId":"NCT06883240","phase":"","title":"An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-04-29","conditions":"Von Willebrand Disease, Type 3","enrollment":40},{"nctId":"NCT05421741","phase":"PHASE4","title":"Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2023-05-15","conditions":"Osteomyelitis Tibia, Tibial Fractures, Open Tibia Fracture","enrollment":484},{"nctId":"NCT05964010","phase":"NA","title":"Primary Connections for Youth and Families","status":"RECRUITING","sponsor":"The National Center on Addiction and Substance Abuse at Columbia University","startDate":"2024-03-01","conditions":"Substance Use","enrollment":2300},{"nctId":"NCT05962606","phase":"PHASE2","title":"Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.","status":"COMPLETED","sponsor":"Aptarion Biotech AG","startDate":"2024-02-02","conditions":"Community-acquired Pneumonia","enrollment":150},{"nctId":"NCT05889494","phase":"NA","title":"Autologous Whole Blood Management for Transfusion Reduction in Adult Cardiac Surgery Patients","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2025-03-24","conditions":"Postoperative Hemorrhage, Postoperative Anemia, Postoperative Blood Loss","enrollment":64},{"nctId":"NCT06962800","phase":"PHASE3","title":"A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)","status":"RECRUITING","sponsor":"Biogen","startDate":"2025-05-22","conditions":"Primary Membranous Nephropathy","enrollment":180},{"nctId":"NCT07477418","phase":"PHASE1, PHASE2","title":"PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP)","status":"NOT_YET_RECRUITING","sponsor":"University of Vermont","startDate":"2026-12","conditions":"Pancreatic Ductal Adenocarcinoma (PDAC), Borderline Resectable Pancreatic Cancer, Pancreatic Neoplasms","enrollment":10},{"nctId":"NCT07476547","phase":"NA","title":"Hypnotic Communication To Reduce Anxiety And Pain During Prostate Biopsy (HYCapp)","status":"COMPLETED","sponsor":"Fondazione del Piemonte per l'Oncologia","startDate":"2025-03-11","conditions":"Anxiety, Pain","enrollment":100},{"nctId":"NCT04077463","phase":"PHASE1","title":"A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2019-09-04","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":701},{"nctId":"NCT06446739","phase":"NA","title":"LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM)","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2024-11-14","conditions":"Acute Kidney Injury, Dialysis; Complications","enrollment":100},{"nctId":"NCT07264699","phase":"NA","title":"Visually Guided TAP Block in Laparoscopic TAPP Hernia Repair","status":"RECRUITING","sponsor":"University of Warmia and Mazury in Olsztyn","startDate":"2025-12-04","conditions":"Inguinal Hernia Repair, Postoperative Pain, TAP Block","enrollment":100},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT07133555","phase":"NA","title":"Safe Spaces 4 Sexual Health","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-08-10","conditions":"HIV Counseling and Testing, HIV Risk Behavior, HIV Prevention","enrollment":100},{"nctId":"NCT06885086","phase":"","title":"ERAS (Enhanced Recovery After Surgery) and Multimodal Analgesia in Laparoscopic Cholecystectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cukurova University","startDate":"2025-06-13","conditions":"Laparoscopic Cholecystectomy","enrollment":120},{"nctId":"NCT02836080","phase":"NA","title":"Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2016-09","conditions":"Mental Disorders, Addiction","enrollment":247},{"nctId":"NCT07475949","phase":"PHASE3","title":"Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":352},{"nctId":"NCT07475936","phase":"","title":"Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":392},{"nctId":"NCT04419480","phase":"NA","title":"Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial","status":"RECRUITING","sponsor":"Inova Health Care Services","startDate":"2020-12-31","conditions":"Cardiogenic Shock, Heart Failure, Ambulatory Hemodynamic Monitoring","enrollment":40},{"nctId":"NCT05114746","phase":"PHASE2","title":"Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-01-25","conditions":"Prostate Cancer","enrollment":87},{"nctId":"NCT07472868","phase":"PHASE3","title":"Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"J. W. A. Burger","startDate":"2026-03-03","conditions":"Locally Advanced Rectal Carcinoma","enrollment":394},{"nctId":"NCT07237750","phase":"NA","title":"iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss","status":"RECRUITING","sponsor":"Liu Yan","startDate":"2026-03-01","conditions":"Overweight and/or Obesity, Metabolic Syndrome, Nonalcoholic Fatty Liver Disease","enrollment":216},{"nctId":"NCT04175600","phase":"PHASE3","title":"A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Actelion","startDate":"2020-01-16","conditions":"Hypertension, Pulmonary","enrollment":138},{"nctId":"NCT06120140","phase":"PHASE2","title":"Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-02-16","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":300},{"nctId":"NCT04316221","phase":"NA","title":"Effects of Complementary Feeding of Eggs on Infant Development and Growth in Guatemala: The Saqmolo Study","status":"COMPLETED","sponsor":"Academy of Nutrition and Dietetics","startDate":"2021-04-01","conditions":"Growth, Development; Delayed","enrollment":1200},{"nctId":"NCT07418437","phase":"NA","title":"Adapting and Pilot Testing a Loneliness Intervention for Cancer Survivors","status":"ENROLLING_BY_INVITATION","sponsor":"University of Washington","startDate":"2026-03-09","conditions":"Cancer Survivorship, Loneliness","enrollment":36},{"nctId":"NCT07387367","phase":"PHASE3","title":"A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT","status":"RECRUITING","sponsor":"SymBio Pharmaceuticals","startDate":"2026-02-15","conditions":"Adenovirus Infections","enrollment":180},{"nctId":"NCT06242483","phase":"NA","title":"The ELFIE-HYPERTENSION","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Israelita Albert Einstein","startDate":"2024-06-14","conditions":"Hypertension","enrollment":930},{"nctId":"NCT05639556","phase":"","title":"Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2023-04-20","conditions":"Cystic Fibrosis","enrollment":300},{"nctId":"NCT07194070","phase":"","title":"A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2025-02-20","conditions":"Hemolytic Disease of the Fetus and Newborn","enrollment":175},{"nctId":"NCT04266886","phase":"NA","title":"Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-09-11","conditions":"Malignant Female Reproductive System Neoplasm, Recurrent Malignant Female Reproductive System Neoplasm, Metastatic Cervical Cancer","enrollment":152},{"nctId":"NCT03164616","phase":"PHASE3","title":"Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2017-06-01","conditions":"Non Small Cell Lung Cancer NSCLC","enrollment":1186},{"nctId":"NCT05492955","phase":"NA","title":"Implementation of a Combination Intervention for Sustainable Blood Pressure Control","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2022-11-30","conditions":"Hypertension","enrollment":774},{"nctId":"NCT04838769","phase":"NA","title":"REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2021-09-15","conditions":"Benign Prostatic Hyperplasia (BPH)","enrollment":154},{"nctId":"NCT07100730","phase":"PHASE3","title":"Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma","status":"RECRUITING","sponsor":"Telix Pharmaceuticals (Innovations) Pty Limited","startDate":"2025-11-02","conditions":"Neoplastic Disease, Glioblastoma, Glioblastoma (GBM)","enrollment":50},{"nctId":"NCT07416526","phase":"PHASE3","title":"A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A","status":"NOT_YET_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2026-05-09","conditions":"Hemophilia A","enrollment":126},{"nctId":"NCT07463690","phase":"NA","title":"Construction and Evaluation of a Flipped Discharge Model for Stomates With Colorectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2026-03-10","conditions":"Colorectal Cancer, Stoma","enrollment":200},{"nctId":"NCT06766162","phase":"NA","title":"Virtual Reality to Improve Patient Experience During Endoscopic Mucosal and Submucosal Resection","status":"COMPLETED","sponsor":"King's College Hospital NHS Trust","startDate":"2025-05-10","conditions":"VR, Virtual Reality Pain Distraction, Endoscopic Submucosal Dissection","enrollment":40},{"nctId":"NCT04862221","phase":"PHASE2","title":"TReatment for ImmUne Mediated PathopHysiology","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2022-02-09","conditions":"Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy","enrollment":163},{"nctId":"NCT07201116","phase":"NA","title":"Health-GIS Platform for Hip Replacement Rehabilitation Coordination","status":"COMPLETED","sponsor":"Tulip Medicine","startDate":"2024-11-28","conditions":"Hip Arthroplasty Replacement, Hip Arthroplasty, Total, Rehabilitation","enrollment":142},{"nctId":"NCT07327463","phase":"","title":"Ultrasound-Guided Transversus Abdominis Plane Block Versus Epidural Block for Umbilical Hernia Analgesia","status":"RECRUITING","sponsor":"Sakarya University","startDate":"2026-01-15","conditions":"Umbilical Hernia, Postoperative Pain Management","enrollment":30},{"nctId":"NCT07462793","phase":"NA","title":"COntinuous Glucose Monitoring in nEwborns of Mothers With Insulin-Treated Gestational Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Institute of Mother and Child, Warsaw, Poland","startDate":"2026-03","conditions":"Neonatal Hypoglycemia, Gestational Diabetes Mellitus (GDM)","enrollment":120},{"nctId":"NCT04716699","phase":"PHASE1","title":"Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2021-01-20","conditions":"Glioblastoma","enrollment":12},{"nctId":"NCT05208892","phase":"NA","title":"Dexmedetomidine Use in SZMN Blocks for Pediatric T&A Pain Control","status":"COMPLETED","sponsor":"Stanford University","startDate":"2024-01-29","conditions":"Postoperative Pain, Opioid Use","enrollment":114},{"nctId":"NCT07457099","phase":"","title":"Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Zhujiang Hospital","startDate":"2026-04-01","conditions":"Locally Advanced Oral Squamous Cell Carcinoma, Locally Advanced Oropharyngeal Squamous Cell Carcinoma","enrollment":85},{"nctId":"NCT07458867","phase":"","title":"International Multi-center Profile of Emergency Large-Bowel Obstruction Management and Outcomes","status":"NOT_YET_RECRUITING","sponsor":"European Society for Trauma and Emergency Surgery","startDate":"2026-07-01","conditions":"Large Bowel Obstruction","enrollment":500},{"nctId":"NCT07458087","phase":"NA","title":"Accuracy of the Accuro 3S","status":"NOT_YET_RECRUITING","sponsor":"Yale University","startDate":"2026-07-15","conditions":"Neuraxial Technique","enrollment":50},{"nctId":"NCT03178552","phase":"PHASE2, PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2017-09-22","conditions":"Non-Small Cell Lung Cancer","enrollment":1000}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["SoC","Hydroxycarbamide","Bevacizumab","Sunitinib","Octreotide (Sandostatin LAR)"],"phase":"marketed","status":"active","brandName":"Local Standard of Care","genericName":"Local Standard of Care","companyName":"Istituto Oncologico Veneto IRCCS","companyId":"istituto-oncologico-veneto-irccs","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Local Standard of Care refers to the established treatment protocols and therapeutic approaches used at Istituto Oncologico Veneto IRCCS for their patient population, rather than a single defined drug entity. Used for Variable depending on trial context; typically cancer types treated at Istituto Oncologico Veneto IRCCS.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}